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Chromatin immunoprecipitation followed by massively parallel sequencing (ChIP-Seq) is a 
powerful technique to map the genomic location of a given chromatin bound factor (i.e., 
transcription factors, co-factors) or epigenetic marks, such as histone modification. The 
procedure is based on, crosslinking of proteins to DNA followed by the capture of the protein-
DNA complexes by “ChIP-grade” antibodies. In this chapter we describe in detail the 
experimental method developed in our laboratory to investigate in vivo the DNA binding 
characteristics of a key heterodimeric nuclear receptor, the Retinoid X Receptor (RXR) in 
murine bone marrow derived macrophages. 
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1. Introduction 
Nuclear hormone receptors are lipid activated transcription factors that regulate gene 
expression in a ligand dependent manner. They possess an evolutionarily conserved domain 
structure, which consists of a DNA binding domain responsible for the recognition of a 
specific motif encoded in the genome, a ligand binding domain for binding the activator 
ligand and the transactivation domain for transcription initiation. Ligand binding leads to 
conformation changes on the surface of the receptor, followed by a co-repressor - co-activator 
switch/exchange, which then results in a distinct change in gene transcription (reviewed in 1). 
RXR is an essential member of the nuclear receptor family, because it forms heterodimers 
with other nuclear hormone receptors (Liver X Receptor, LXR; Peroxisome Proliferator 
Activated Receptor, PPAR; Retinoic Acid Receptor, RAR etc.) that  regulate indispensable 
biological processes such as inflammation, lipid and glucose metabolism (2, 3). RXR was 
discovered as a novel retinoid responsive transcription factor (4). Several ligands, such as 9-
cis retinoic acid, docosahexanoic acid and phytanic acid have been shown to activate the 
receptor, although their action as endogenous ligands under physiological conditions have not 
been proven yet (5).  There are also specific and selective synthetic agonists of RXR, such as 
LG100268 or LG10069 (Bexarotene) (6, 7).  
RXR has three different isotypes in metazoans (RXR, RXR, RXR), which display 
differential expression patterns in different tissues. For example, RXR is expressed in heart, 
liver, kidney, spleen and placenta epidermis, RXR is specific to brain and muscle, while 
RXR is ubiquitous (5). The phenotypes attributable to these isoforms have been well 
characterized. For instance, abolished expression of RXR was shown to be lethal at 
embryonic stage E13.5-16.5 mostly due to cardiac abnormalities, while the lack of RXR or 
RXR was not fatal, but resulted in male infertility and increased metabolic rate. These 
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studies also revealed a locomotor deficiency in RXR/ double knock out mice (8, 9).  In cells 
of myeloid origin RXR appears to be the dominant isoform (10, 11). 
On the other hand, activation of RXR and the molecular details of RXR mediated gene 
expression remains enigmatic, because: 1. Definitve proof for a biological role for an 
endogenous ligand is still lacking. 2. It is not clear if it also has heterodimer independent 
activities.  
ChIP-Seq has become the most widely used and effective method to study chromatin state 
and transcription factor distribution at the genomic level. ChIP was almost the first 
application linked to next generation sequencing and the one leading to the determination of 
the typical histone acetylation and methylation patterns of gene promoters, enhancers, 
insulators and repressed chromatin territories (12). ChIP-Seq also allows the determination of 
the “cistrome” of any transcription factor meaning - all the binding sites in a given cell type 
under given circumstances, which was first carried out for Signal Transducer and Activator of 
Transcription (STAT) 1 (13). Macrophages are a major target of research including studies on 
immune function, but also in metabolism and transcriptional regulation as well (14, 15).  This 
is not only because their relatively easy accessibility, but also due to their importance in 
physiological as well as pathological processes. 
In order to better understand the molecular mechanisms by which RXR regulates gene 
expression in a genome-wide manner in murine bone marrow derived macrophages, a 
protocol was developed in our laboratory to accurately map the receptor binding sites using 
ChIP-Seq.  This protocol is described in this chapter (Figure 1).  
The protocol here described is optimized to murine bone marrow derived macrophages. A 
similar approach was used by us to determine the RXR cistrome in HeLa cells (16).  





1. Bone marrow derived macrophages obtained from the femur of C57Bl6/J male 
animals as described (17). Briefly, bone-marrow was flushed, cells were purified 
through a Ficoll-Paque gradient and cultured in DMEM containing 20% endotoxin-
reduced fetal bovine serum and 30% L929 conditioned medium for 5 days. On the 
sixth day DMEM is replaced to Macrophage serum free media for 24 hours, then 
treatments are performed. 
2. DSG Di (N-succinimidyl) glutarate (see Note 1). 
3. DMSO (dimethyl-sulfoxide). 
4. DMSO/EtOH (1:1) as vehicle treatment. 
5. LG268 (Ligand Pharmaceuticals) dissolved in DMSO/EtOH 
6. Ultrapure formaldehyde 16% (Thermo Scientific, PI-28906) (see Note 1). 
7. 1M Glycine. 
8. PBS (Phosphate Buffered Saline).  
9. Roche Complete Mini Protease Inhibitor Tablets (EDTA-free). 
10. Cell Lysis/ Wash Buffer: 0.15M NaCl, 0.005M EDTA pH 7.5, 0.05M Tris-HCl pH 
7.5, 0.5% NP40, dH2O supplemented with protease inhibitor (Roche) prior to use. 
Store at 4 C. 
11. 1 ml Insulin syringe. 
12. Shearing Buffer 0.05M Tris-HCl, pH 8.0, 1% SDS, 0.01M EDTA, dH2O 
supplemented with protease inhibitor tablets (Roche) prior to use. Store at room 
temperature. (see Note 4) 
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13. Dilution Buffer: 0.001M EDTA, pH 8.0, 0.01% SDS, 1.1% Triton-X 100, 0.17M 
NaCl, dH2O supplemented with protease inhibitor tablets (Roche) prior to use. Store at 
4°C. 
14. 0.5% Bovine Serum Albumin (BSA)/ PBS. Filter through 0.22 μm filter using a 
syringe. Prepare freshly before use. 
15. IgG (Millipore) 
16. ChIP-grade antibody to RXR (Santa Cruz Biotechnology). 
17. 15 ml conical tubes (polystyrene) (see Note 6). 
18. 100% Ethanol (ETOH). 
19. Agilent 2100 Bioanalyzer with 7500 chips for inputs, 1000 chips for DNA libraries. 
20. Axygen LoBind tubes (1.5ml) 
21. Dynabeads® Protein A (10002D) 
22. PBS containing 0.5% BSA (filter through a 0.22 μm filter using syringe) 
23. Magnetic Rack for 1.5ml eppendorf tubes and for 15ml conical tubes 
24. TE buffer: 10mM Tris HCl pH 8.0, 1mM EDTA, dH2O (without protease inhibitor). 
Store at 4°C. 
25. Bead Elution Buffer: 0.1M NaHCO3, 1% SDS, dH2O (make fresh immediately before 
elution) 
26. RNase A 10μg/μl. 
27. Proteinase K 20 μg/μl. 
28. 3M Sodium acetate, pH 5.2. 
29. Qiagen MinElute PCR Purification Kit. 
30. Sonicator, Diagenode Bioruptor® standard (Cat. No. UCD-200). 
31. Thermomixer. 
32. Rotating Tube Rack or platform in cold room. 
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33. Ovation Ultralow Library Systems (Nugen). 
3. Methods 
Prepare the lysis, dilution and shearing buffers by dissolving the protease inhibitor tablets 
according to the manufacturer’s instructions. Make sure that you have sufficient amount of 
PBS at room temperature and at 4°C (20 ml ice-cold PBS for washing/ plate, 20 ml PBS at 
room temperature for cross-linking/ plate). 
3.1 Crosslink and harvest the cells 
1. Approximately 3x107 bone marrow derived macrophages are used as starting material 
for transcription factor ChIP-Seq. About 107 cells are seeded per plate (15 cm 
diameter) and the chromatin obtained from three plates is combined during the 
experiment for each reaction.  
2. Treat the cells with vehicle (DMSO/EtOH) or 100 nM LG268 for 1 hour or more, 
depending on the given experiment. 
3. Dissolve DSG in DMSO (50mg DSG is dissolved in 300 μl DMSO yielding a 0.5M 
DSG solution (see Note 1). 
4. Dilute DSG to 0.002M in PBS, at room temperature. 
5. Remove the medium from the cells and pipette 10 ml of DSG containing PBS onto the 
plates. 
6. Incubate for 30 minutes at room temperature. Gently swirl the plates every 5 minutes.  
7. During the last 5 minutes, prepare 1% formaldehyde solution in PBS at room 
temperature (see Note 1). 
8. After incubation, aspirate the DSG solution and replace it with 10 ml 1% 
formaldehyde solution. Incubate for 10 minutes at room temperature. Gently swirl the 
plates every 2 minutes. Make sure that the DSG solution is completely discarded 
before adding the formaldehyde solution (see Note 2).  
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9. Add 1.5 ml of 1M glycine directly to the formaldehyde containing solution and 
incubate the cells at room temperature for an additional 5 minutes, while gently swirl 
the plate in every minute.  
10. Place the samples on ice.  
11. Aspirate the liquid from the plates and wash the cells twice with ice-cold PBS. Make 
sure that after the second wash all the supernatant is discarded, then immediately 
proceed to lysis. 
3.2 Cell lysis and chromatin shearing 
1. Scrape up the cells from each plate in 1 ml Cell Lysis/Wash Buffer containing 
appropriate amount of protease inhibitors (see Note 3). 
2. Transfer the lysates to 1.5 ml centrifuge tubes. 
3. Centrifuge with 12.000 x g for one minute at 4°C. 
4. Remove the supernatant and add 1 ml of Cell Lysis/ Wash Buffer. 
5. Pipette up and down the cells at least 20 times to get homogenous cell suspension, and 
then push through the whole volume in a 1 ml insulin syringe. 
6. Repeat the step 3. 
7. Remove the supernatants and combine the pellets into one centrifuge tube, using the 
same 1 ml Lysis Buffer. Push the whole volume again through a 1 ml insulin syringe. 
8. Repeat the step 3. 
9. Remove the supernatant and resuspend the nuclear pellet in 1 ml of room temperature 
Shearing Buffer (see Note 4).  
10. Gently pipette up and down at least 30 times to generate a homogenous suspension 
and take care not to generate bubbles (see Note 5). 
11. Transfer the solutions into 15 ml conical tubes (polystyrene) (see Note 6) and place 
the sonicator probes into the tubes (see Note 7)  
 9 
12. Sonicate the chromatin to get fragments between 200-500 bp. Using the Diagenode 
Bioruptor® Standard model, 3 x 5 minute long cycles are used, with 30 seconds on, 30 
seconds off set-up. The first sonication cycle is carried out at high and the other two at 
low power setting (3 cycles, 15 minutes) (see Note 8 and Note 9).  
13. Transfer the sheared chromatin to 1.5ml tubes and centrifuge at 12.000x g for 10 
minutes at 4°C. Set aside 20 μl of sheared chromatin as input to check the fragment 
size distribution and normalize quantitative PCR measurements (see Note 10). 
14. Transfer 900 μl supernatant to a new 15 ml conical tube and dilute 10 fold by adding 
8.1 ml Dilution Buffer containing protease inhibitors. The diluted chromatin can be 
stored for 24 hours at 4°C. 
3.3 Immunoprecipitation 
1. Add 5 μg of anti-RXR antibody to each diluted chromatin.  
2. Set aside at least 1 ml of diluted chromatin and add 5 μg of pre-immune rabbit IgG, as 
a control of nonspecific binding. 
3. Incubate the samples overnight at 4°C, using an ‘end-over-end’ rotator.  
4. On the day of immunoprecipitation, pre-block the paramagnetic beads. For each 
immunoprecipitation, prepare 190 μl of beads. Wash the beads three times with 1 ml 
of PBS containing 0.5% BSA, using the magnetic rack appropriate for 1.5 ml 
centrifuge tubes. Incubate the beads overnight at 4°C using rotator (see Note 11). 
5. After overnight incubation, centrifuge the chromatin antibody complexes at 3500 rpm 
for 20 minutes at 4°C. 
6. Use the top 90% of the centrifuged chromatin for bead binding (see Note 12). 
7. Use the magnetic rack to collect the beads and replace the supernatant with 190 μl of 
PBS containing 0.5% BSA. 
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8. Combine the beads with the antibody chromatin complexes and incubate for at least 
four hours at 4°C using the rotator (see Note 13). 
9. Prepare appropriate amount of Cell Lysis/ Wash Buffer by adding 1 protease inhibitor 
tablet to 50 ml of Cell Lysis/ Wash Buffer. 
10. Place the tubes containing the antibody-chromatin-bead complexes on a magnetic rack 
at 4°C. 
11. Incubate for 2 min or until the liquid appears clear, and then aspirate the supernatant. 
12.  Add the same volume of Cell Lysis/ Wash Buffer as the immunoprecipitation volume 
(RXR-8 ml, IgG-1 ml) and rotate the tubes for 3 minutes at 4°C. 
13. Wash (six times) the complexes with Cell Lysis/ Wash Buffer. Carefully remove all 
traces of buffer at the end of the last washing step, without disturbing the beads and 
place the tubes on ice. 
14. Add 1 ml ice-cold TE Buffer. Gently pipette up and down to generate homogenous 
bead slurry then transfer the whole volume to a 1.5 ml LoBind tube. 
15. Place the LoBind tubes on a magnetic rack, which stands on ice. Wait until the liquid 
appears clear then remove the supernatant (see Note 14). 
3.4 Bead elution, de-crosslinking and DNA purification 
The remaining part of the protocol should be carried out at room temperature. 
1. Add 100 μl Bead elution buffer to each tube and vortex at moderate speed for a few 
seconds. Place the samples on a thermomixer for 15 minutes and shake at 1000 rpm. 
2. Place the tubes back on the magnetic rack and collect the supernatant into clean 
LoBind tubes. 
3. Repeat  the step 1. 
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4. After the second elution step, add 8 μl of 5M NaCl to each sample and incubate 
overnight at 65°C to de-crosslink the immunoprecipitated chromatin. Process the input 
DNA in the same way for QPCR measurements. 
5. On the following day, add 1 μl of 10 μg/ μl RNase A to each sample and incubate for 
30 minutes at 37°C. 
6. Add 8 μl of 1M Tris-HCl, pH 8.0, 4 μl of 0.5M EDTA and 1 μl of 20 μg/ ml 
Proteinase K and incubate for at least 2 hours at 45°C on a thermomixer at 1000 rpm. 
7. Purify the immunoprecipitated DNA (total volume 222 μl) using Qiagen MinElute 
columns, according to manufacturer’s instruction. 
8. Add 1110 μl PB Buffer to each sample and acidify the solution by adding 50 μl of 3M 
sodium acetate (see Note 15). 
9. Elute the immunoprecipitated DNA in 15 μl Elution Buffer. 
10. Proceed to library preparation and/or QPCR measurements. 
11. For library preparation the Ovation Ultralow Library Systems is used. Libraries are 
generated from 5 ng of immunoprecipitated DNA, according to manufacturer’s 
protocol (see Note 16). 
4. Notes 
1. Dissolve DSG immediately before use as it is highly unstable in solution and always 
use freshly opened formaldehyde ampulla for cross-linking. Otherwise, the cross-
linking efficiency might be seriously affected. 
2. Make sure that all the DSG is discarded before formaldehyde cross-linking, since DSG 
and formaldehyde cross-reaction might lead to quenched formaldehyde efficiency.  
3. Scraping up the cells in PBS will cause the cells to stick to the wall of the centrifuge 
tubes during centrifugation that causes a subsequent loss in cell number. 
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4. Store and use Shearing Buffer at room temperature, because SDS precipitation occurs 
at 4°C. This negatively affects sonication efficiency. If SDS precipitation occurs in the 
nuclear lysate, allow the solution to come to room temperature before sonication. 
5. Be careful not to generate bubbles during lysis, which can negatively affect sonication 
efficiency. 
6. It is highly recommended to use polystyrene tubes, instead of polypropylene, since 
polystyrene transfers sonic waves more efficiently. 
7. The probes should be set exactly in the middle of the tube submerged in the solution. 
If the probes come in contact with the inner surface of the tubes it might negatively 
affect sonication efficiency. 
8. Check the position of the probes after each sonication cycle to make sure they not to 
touch the tube.  
9. In order to determine the optimal sonication conditions for your cells perform a series 
of experiment with different power, cycle number, etc. Use the condition resulting in 
the highest enrichment of a positive control region after QPCR measurement, which 
typically gives the best sequencing results. For QPCR measurements of RXR ChIP, 
we used the following primers: Abca1 -78bp Fw: TGCCGCGACTAGTTCCTT, 
Abca1 -78bp Rev: TCTCCACGTGCTTTCTGCT, Abcg1 +1kb Fw: 
CCGAATCGTGCCTTTCTTT, Abcg1 +1kb Rev: GTGGGCTTCTAGCGTATTG. As 
a negative control region use: 36b4 Fw: GGGGAGATCCCAAGACTACAG, 36b4 
Rev: CCACGCGCTTTAACAGAGTT 
10. For input isolation, add 3 volumes of 100% EtOH to the 20 μl sheared chromatin, 
vortex and incubate overnight at -80°C. The next day, centrifuge it for 10 minutes at 
maximum speed (4°C). Remove the supernatant, dry the DNA pellets and dissolve in 
200 μl Elution Buffer. Process input DNA from step 4 in section 3.4. 
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11. Avoid that magnetic beads remain in the bottom of the tubes, since it causes 
incomplete blocking and high background signal after sequencing. Therefore, transfer 
the tubes immediately from the magnetic rack to the rotator before the overnight 
blocking step.   
12. Be careful not to disturb the chromatin-antibody complexes after centrifugation. Use 
only the top 90% of the sample to avoid high background signal. 
13. To avoid incomplete mixing of the magnetic beads and the antibody-chromatin 
complexes see Note 11 for instructions. 
14. Use 1 ml pipette tips to remove all the supernatants at this step, because the beads are 
loosely attached to the tube surface. 
15. Adsorption of DNA to the silica during column purification is drastically reduced at 
higher pH. It is important to follow the manufacturer’s instructions to acidify the DNA 
solution prior to binding to the column.  
16. To determine the background of the experiment prepare control libraries with the input 
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6. Figure Legend 
Figure 1. Schematic representation of the main steps of the ChIP-Seq protocol.  
